Biodesix, Inc.
BDSX
$0.2867
-$0.0132-4.40%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -34.54% | 19.57% | 5.09% | 20.61% | -48.97% |
| Total Depreciation and Amortization | -0.62% | -2.88% | 5.67% | -0.56% | 8.81% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -12.21% | 16.10% | -30.96% | -32.96% | 66.78% |
| Change in Net Operating Assets | -212.31% | 117.93% | 68.72% | -69.31% | -2.88% |
| Cash from Operations | -110.01% | 61.62% | 42.54% | -21.29% | -24.65% |
| Capital Expenditure | 91.18% | -263.20% | 88.01% | -723.08% | 92.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -40.00% | 18.18% | 22.54% | -82.05% | -129.41% |
| Cash from Investing | 84.50% | -209.09% | 85.68% | -631.50% | 90.90% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 46.15% | 0.00% | -8.33% | 7.69% | 0.00% |
| Issuance of Common Stock | 4,371.43% | -98.02% | -99.36% | 5,944.40% | -92.90% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -19.43% | 11.17% | 94.67% | -3,386.79% | 90.09% |
| Cash from Financing | 153.59% | -225.69% | -99.72% | 6,384.96% | -96.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -67.45% | 52.27% | -135.19% | 307.72% | -329.56% |